Dowling & Yahnke’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $359K | Buy |
4,343
+78
| +2% | +$6.45K | 0.02% | 303 |
|
|
2022
Q2 | $406K | Sell |
4,265
-96
| -2% | -$9.14K | 0.02% | 292 |
|
|
2022
Q1 | $513K | Buy |
4,361
+400
| +10% | +$47.1K | 0.02% | 278 |
|
|
2021
Q4 | $513K | Sell |
3,961
-32
| -0.8% | -$4.14K | 0.02% | 274 |
|
|
2021
Q3 | $452K | Hold |
3,993
| – | – | 0.03% | 273 |
|
|
2021
Q2 | $414K | Sell |
3,993
-155
| -4% | -$16.1K | 0.02% | 272 |
|
|
2021
Q1 | $347K | Buy |
4,148
+101
| +2% | +$8.45K | 0.02% | 277 |
|
|
2020
Q4 | $369K | Buy |
4,047
+900
| +29% | +$82.1K | 0.03% | 269 |
|
|
2020
Q3 | $251K | Buy |
3,147
+66
| +2% | +$5.26K | 0.02% | 283 |
|
|
2020
Q2 | $213K | Buy |
+3,081
| New | +$213K | 0.02% | 283 |
|
|
2020
Q1 | – | Sell |
-3,186
| Closed | -$248K | – | 311 |
|
|
2019
Q4 | $248K | Sell |
3,186
-24
| -0.7% | -$1.87K | 0.02% | 279 |
|
|
2019
Q3 | $235K | Buy |
+3,210
| New | +$235K | 0.02% | 282 |
|
|
2018
Q1 | – | Sell |
-5,808
| Closed | -$218K | – | 286 |
|
|
2017
Q4 | $218K | Buy |
+5,808
| New | +$218K | 0.02% | 279 |
|